Birth control patch warning about blood clots - Evra contraceptive patch - Health Canada

Birth control patch warning about blood clots - Evra contraceptive patch - Health Canada: "Janssen-Ortho Inc., in consultation with Health Canada, wishes to highlight important new safety information pertaining to Evra. The Evra transdermal system marketed in Canada contains 6.0 mg norelgestromin (NGMN) and 0.60 mg ethinyl estradiol (EE) and is approved for use in contraception (prevention of pregnancy)." [SpiritIndia]